VYNE icon

VYNE Therapeutics

64 hedge funds and large institutions have $20.1M invested in VYNE Therapeutics in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

50% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 16

69% less capital invested

Capital invested by funds: $64M → $20.1M (-$43.9M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
64
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$140K
Puts
$32K
Net Calls
Net Calls Change

Top Buyers

1 +$1.3M
2 +$151K
3 +$128K
4
Northern Trust
Northern Trust
Illinois
+$76.3K
5
Two Sigma Investments
Two Sigma Investments
New York
+$47.6K

Top Sellers

1 -$4.79M
2 -$557K
3 -$499K
4
CSS
Cubist Systematic Strategies
Connecticut
-$426K
5
Axa
Axa
France
-$423K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.39M
2
$3.24M
3
$2.67M
4
$1.73M
5
$1.53M
6
$1.44M
7
$994K
8
$756K
9
$653K
10
$601K
11
$556K
12
$271K
13
$213K
14
$200K
15
$188K
16
$154K
17
$151K
18
$138K
19
$128K
20
$113K
21
$111K
22
$108K
23
$101K
24
$81K
25
$70K